Claudine Sylvester, MD
Obstetrics & Gynecology · West Orange, NJNPI 1033263744
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Celularity Inc. at 48.9% of the total. Reporting peaked in 2019 at $1,285 and has fallen 86.3% since, to $176 in 2024.
Across 94 payments — averaging $34.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$2K
- Davol Inc.$179
- Exeltis, USA Inc.$165
- C. R. Bard, Inc. & Subsidiaries$141
- AbbVie$125
- Evofem Biosciences, Inc.$94
- plus $932 from 23 others
What the payments were for
- Speaking & faculty fees$1,55048%
- Travel & lodging$1093%
- Food & beverage$1,50847%
- Education$331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 7 | $1,565 |
| Davol Inc. | 2 | $179 |
| Exeltis, USA Inc. | 11 | $165 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $141 |
| AbbVie(2 entities) | 9 | $125 |
| Evofem Biosciences, Inc. | 7 | $94 |
| Bayer | 3 | $92 |
| Astellas Pharma US Inc | 4 | $89 |
| Avion Pharmaceuticals | 6 | $82 |
| Mayne Pharma Commercial LLC | 5 | $79 |
| Millicent US Inc | 5 | $76 |
| Pfizer | 4 | $69 |
| Daiichi Sankyo Inc. | 5 | $68 |
| Therapeuticsmd, Inc. | 3 | $37 |
| Organon | 2 | $34 |
| Dysis Medical, Inc. | 2 | $33 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Merck | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Agile Therapeutics, Inc. | 2 | $27 |
| Myovant Sciences Inc. | 2 | $27 |
| Lupin Inc. | 2 | $26 |
| Roche Diagnostics Corporation | 1 | $23 |
| Aspira Women's Health Inc | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $15 |
| Coopersurgical, Inc. | 1 | $13 |
| Meditrina | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,199 in reported general payments places this provider in the 85th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $1,459 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $305 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in West Orange
- Susan PitmanWest Orange$77K
- Robert RubinoWest Orange$42K
- Jacqueline SaittaWest Orange$9K
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.